| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |